Table 1. Clinical and Epidemiologic Profile of Patients With Inflammatory Bowel Disease (n = 56).
| Variable | UCa (n = 30) | CDb (n = 26) | Overall (n = 56) |
|---|---|---|---|
| Females | 19 | 16 | 35 |
| Age (years)c | 42 (14) | 44 (15) | 43 (14) |
| Reduced fecal elastased | 5 | 5 | 10 |
| Elevated serum IgG4e | 9 | 1 | 10 |
| Active diseasef | 14 | 8 | 22 |
| Extraintestinal manifestations | 3 | 0 | 3 |
| Time elapsed since diagnosis (months)c | 67 (71) | 69 (46) | 68 (61) |
aUlcerative colitis. bCrohn’s disease. cMean (standard deviation). dNumber of patients with fecal elastase level < 200 μg/g of stool. eNumber of patients with serum IgG4 level > 140 mg/dL. fNumber of patients with active disease as defined by the Lichtiger clinical-activity index (UC) or the Crohn’s disease activity index (CD).